GCIA
IMMU

Gabelli & Co Investment Advisers’s Immunomedics Inc IMMU Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-257,000
Closed -$21.9M – 390
2020
Q3 		$21.9M Buy
+257,000
New +$13M 3.94% 3

Gabelli & Co Investment Advisers's IMMU Position: Q4 2020 in Review

Gabelli & Co Investment Advisers sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 257,000 shares — an estimated $21.9M sold.

Gabelli & Co Investment Advisers first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $21.9M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Gabelli & Co Investment Advisers reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 257,000 Immunomedics Inc shares in Q4 2020, an estimated $21.9M.
  • Gabelli & Co Investment Advisers first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's Immunomedics Inc position peaked at $21.9M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2020, filed 5 Feb 2021.